95 related articles for article (PubMed ID: 11492990)
1. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.
Cleland JG; Thygesen K; Uretsky BF; Armstrong P; Horowitz JD; Massie B; Packer M; Poole-Wilson PA; Rydén L;
Eur Heart J; 2001 Sep; 22(17):1601-12. PubMed ID: 11492990
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
Rydén L; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Packer M; Poole-Wilson PA
Eur Heart J; 2000 Dec; 21(23):1967-78. PubMed ID: 11071803
[TBL] [Abstract][Full Text] [Related]
3. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
4. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
[TBL] [Abstract][Full Text] [Related]
5. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
Saha SA; Molnar J; Arora RR
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
Avanzini F; Ferrario G; Santoro L; Peci P; Giani P; Santoro E; Franzosi MG; Tognoni G;
Am Heart J; 2002 Dec; 144(6):1018-25. PubMed ID: 12486426
[TBL] [Abstract][Full Text] [Related]
7. Causes of death in the ATLAS study: effects of high-dose ACE inhibitors.
Cleland JG
Int J Clin Pract Suppl; 1999 Apr; 100():19-20. PubMed ID: 10658295
[No Abstract] [Full Text] [Related]
8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
10. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
[TBL] [Abstract][Full Text] [Related]
11. What does ATLAS really tell us about "high" dose angiotensin-converting enzyme inhibition in heart failure?
Nicklas JM; Cohn JN; Pitt B
J Card Fail; 2000 Jun; 6(2):165-8. PubMed ID: 10908091
[TBL] [Abstract][Full Text] [Related]
12. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
[TBL] [Abstract][Full Text] [Related]
13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death.
Fischer D; Rossa S; Landmesser U; Spiekermann S; Engberding N; Hornig B; Drexler H
Eur Heart J; 2005 Jan; 26(1):65-9. PubMed ID: 15615801
[TBL] [Abstract][Full Text] [Related]
19. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
[TBL] [Abstract][Full Text] [Related]
20. The ATLAS study: low-dose versus high-dose lisinopril in heart failure.
Horowitz JD
Int J Clin Pract Suppl; 1999 Apr; 100():15-6. PubMed ID: 10658293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
